These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12148128)

  • 1. Acute renal failure secondary to milrinone in a patient with cardiac amyloidosis.
    Saab G; Mindel G; Ewald G; Vijayan A
    Am J Kidney Dis; 2002 Aug; 40(2):E7. PubMed ID: 12148128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative hemodynamic effects of vasopressin and norepinephrine after milrinone-induced hypotension in off-pump coronary artery bypass surgical patients.
    Jeon Y; Ryu JH; Lim YJ; Kim CS; Bahk JH; Yoon SZ; Choi JY
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):952-6. PubMed ID: 16675238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is vasopressin really superior to norepinephrine in reversing milrinone-induced vasodilation?
    Lange M; Van Aken H; Westphal M
    Eur J Cardiothorac Surg; 2006 Oct; 30(4):689. PubMed ID: 16939712
    [No Abstract]   [Full Text] [Related]  

  • 4. Vasopressin as an alternative to norepinephrine in the treatment of milrinone-induced hypotension.
    Gold JA; Cullinane S; Chen J; Oz MC; Oliver JA; Landry DW
    Crit Care Med; 2000 Jan; 28(1):249-52. PubMed ID: 10667533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasopressin in the treatment of milrinone-induced hypotension in severe heart failure.
    Gold J; Cullinane S; Chen J; Seo S; Oz MC; Oliver JA; Landry DW
    Am J Cardiol; 2000 Feb; 85(4):506-8, A11. PubMed ID: 10728962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
    De Hert SG; Lorsomradee S; Cromheecke S; Van der Linden PJ
    Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case report: profound hypotension associated with labetalol therapy in a patient with cerebral aneurysms and subarachnoid hemorrhage.
    Jivraj S; Mazer CD; Baker AJ; Choi M; Hare GM
    Can J Anaesth; 2006 Jul; 53(7):678-83. PubMed ID: 16803915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
    Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic management and outcome of patients treated for cerebral vasospasm with intraarterial nicardipine and/or milrinone.
    Schmidt U; Bittner E; Pivi S; Marota JJ
    Anesth Analg; 2010 Mar; 110(3):895-902. PubMed ID: 20185665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial.
    Aranda JM; Schofield RS; Pauly DF; Cleeton TS; Walker TC; Monroe VS; Leach D; Lopez LM; Hill JA
    Am Heart J; 2003 Feb; 145(2):324-9. PubMed ID: 12595851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vassopressors and inotropes.
    Med Lett Drugs Ther; 2011 Nov; 53(1377):90-2. PubMed ID: 22075670
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacotherapy of severe heart failure with inodilators--new approaches].
    Baumann G; Hader O
    Z Kardiol; 1996; 85 Suppl 4():9-19. PubMed ID: 9027110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term intravenous milrinone for severe congestive heart failure: the good, bad, and not so good.
    Varriale P; Ramaprasad S
    Pharmacotherapy; 1997; 17(2):371-4. PubMed ID: 9085331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized multicenter study comparing the efficacy and safety of intravenous milrinone and intravenous nitroglycerin in patients with advanced heart failure.
    Loh E; Elkayam U; Cody R; Bristow M; Jaski B; Colucci WS
    J Card Fail; 2001 Jun; 7(2):114-21. PubMed ID: 11420762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New inotropic agents in the treatment of congestive heart failure].
    Freitas M
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Additive effects of milrinone and dobutamine in severe heart failure].
    Meissner A; Herrmann G; Gerdesmeyer L; Simon R
    Z Kardiol; 1992 May; 81(5):266-71. PubMed ID: 1621407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopressin effective in reversing catecholamine-resistant vasodilatory shock.
    Lim TW; Lee S; NG KS
    Anaesth Intensive Care; 2000 Jun; 28(3):313-7. PubMed ID: 10853217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant use of nesiritide and milrinone in decompensated congestive heart failure.
    Smull DL; Jorde UP
    Am J Health Syst Pharm; 2005 Feb; 62(3):291-5. PubMed ID: 15719588
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of milrinone on metabolism after cardiopulmonary bypass.
    Tatlis A; Papakonstantinou C; Toumbouras M; Gerolioliou K; Spanos P
    J Cardiovasc Surg (Torino); 2008 Feb; 49(1):113-8. PubMed ID: 18212696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal blood pressure support: the use of inotropes, lusitropes, and other vasopressor agents.
    Noori S; Seri I
    Clin Perinatol; 2012 Mar; 39(1):221-38. PubMed ID: 22341548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.